Sava Infond’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94K Hold
180
– – 0.01% 230
2026
Q2
$94.8K Hold
180
– – 0.01% 224
2026
Q1
$101K Buy
+180
New +$115K 0.01% 214

Other funds holding IDXX

Sava Infond's IDXX Position: Q3 2026 in Review

Sava Infond held its Idexx Laboratories (IDXX) position steady in Q3 2026 at 180 shares worth $94K. The position accounts for 0.01% of the portfolio, ranked #230.

Sava Infond first reported a position in IDXX in Q1 2026 and has held it in 3 quarters since. The position peaked at $101K in Q1 2026. 1,267 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Sava Infond held 180 shares of Idexx Laboratories worth $94K as of Q3 2026.
  • Sava Infond left its Idexx Laboratories share count unchanged in Q3 2026.
  • Idexx Laboratories made up 0.01% of Sava Infond's portfolio in Q3 2026, its #230 holding.
  • Sava Infond first reported a position in Idexx Laboratories in Q1 2026 and has held it in 3 quarters since.
  • Sava Infond's Idexx Laboratories position peaked at $101K in Q1 2026.
  • 1,267 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Sava Infond's 13F filing for Q3 2026, filed 28 Oct 2026.